H2020Индивидуална стипендия2018–2020

BRAIN CAMO · Camouflaging electronics in the brain with immobilized liquid coatings

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2018-11-01 → 2020-10-31
Финансиране от ЕС
183 455 €
Участници
1
Схема
MSCA-IF-EF-ST

Линиите свързват координатора с партньорите.

Накратко на български

Течните покрития върху имплантирани електроди в мозъка се изследват като средство за защита на устройствата от тъканите. Те намаляват травмите при поставянето и подобряват издръжливостта на сондите, което помага за по-доброто проследяване и лечение на заболявания като епилепсия и Паркинсон.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Camouflaging electronics in the brain with immobilized liquid coatings

In the UK alone, those suffering from brain disorders is approximately 45 million and associated healthcare costs exceed 130 billion euros per year. Neural electronics for recording and stimulating brain activity have become invaluable tools to study and treat disorders such as epilepsy, depression, and Parkinson’s. Currently used neural probes often fail in chronic evaluations (>1 year); the stiffness and chemistry of probes induce inflammation, neuronal death, and fibrous capsule formation. In this project, the approach was to use water-immiscible liquids anchored to the surface by a gel to shield neural probes from surrounding tissue. The proposed strategy of these immobilized liquid coatings is applicable to all implantable electronics, including those for other tissues and those based on various materials (silicon, metal, and organics). The objectives of this work were to study the biocompatibility of the material and to study the effects of these coatings on the trauma from insertion. It was concluded these immobilized liquid coatings are just as biocompatible as other materials traditionally used for fabricating neural probes. Furthermore, the immobilized liquid coatings reduce insertion trauma and may therefore be helpful to improve overall performance and longevity of neural probes. These findings may be impactful for a variety of implantable medical devices in which these coatings are applied to help improve patient outcomes post-surgery.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

In the UK alone, those suffering from brain disorders is approximately 45 million and associated healthcare costs exceed 130 billion euros per year. Neural electronics for recording and stimulating brain activity have become invaluable tools to study and treat disorders such as epilepsy, depression, and Parkinson’s. Currently used neural probes often fail in chronic evaluations (>1 year); the stiffness and chemistry of probes induce inflammation, neuronal death, and fibrous capsule formation. When examining a neural probe, the vast majority of the surface area is comprised of the encapsulation material; an insulating polymer that shields electronics from tissue. To date, most studies of implantable electronics have utilized only bare insulation as the tissue-interfacing material, yet in long-term studies, these insulation materials degrade and crack from the in vivo environment and expose the underlying electronics. Furthermore, adherence of proteins and cells to insulation promotes the immune response against the probe. Therefore, introducing an effective barrier between insulation and tissue is a highly promising approach for improving probe biocompatibility and performance. In this proposal, the approach is to use water-immiscible liquids anchored to the surface by a gel to shield neural probes from surrounding tissue. The proposed strategy of these immobilized liquid coatings (ILCs) is applicable to all implantable electronics, including those for other tissues and those based on various materials (silicon, metal, and organics). This proposal will focus solely on organic probes, which can be flexible and have recently been shown to improve biocompatibility by the reducing the mechanical mismatch between probe and brain tissue. Therefore, applying ILCs to organic neural probes will advance the current state-of-the-art and will address chronic biocompatibility on multiple fronts.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз